U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Karyopharm Therapeutics Inc. (KPTI)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
10.63+0.15 (+1.43%)
At close: 4:00PM EDT
People also watch
EPZMMGNXXLRNOMEDPTCT
Full screen
Previous Close10.48
Open10.46
Bid10.45 x 300
Ask10.98 x 5000
Day's Range10.41 - 10.69
52 Week Range6.27 - 14.63
Volume164,275
Avg. Volume186,537
Market Cap501.09M
Beta4.69
PE Ratio (TTM)-3.95
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cancer Space Update: Mixed Week for Pfizer, Roche Falters
    Zacks18 hours ago

    Cancer Space Update: Mixed Week for Pfizer, Roche Falters

    Roche again disappointed this week with two studies on Tecentriq being put on partial hold while Pfizer's Bavencio received approval in Europe. TESARO's Zejula moved a step closer to approval.

  • Karyopharm's Liposarcoma Candidate Superior in Phase II Study
    Zacks2 days ago

    Karyopharm's Liposarcoma Candidate Superior in Phase II Study

    Karyopharm's (KPTI) selinexor reduced the risk of progression or death in previously treated patients with advanced dedifferentiated liposarcoma.

  • Capital Cube22 days ago

    ETFs with exposure to Karyopharm Therapeutics, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Karyopharm Therapeutics, Inc. Here are 5 ETFs with the largest exposure to KPTI-US. Comparing the performance and risk of Karyopharm Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)